Goldman Sachs Initiates Coverage On Zimmer Biomet Holdings with Neutral Rating, Announces Price Target of $129
Portfolio Pulse from Benzinga Newsdesk
Goldman Sachs has initiated coverage on Zimmer Biomet Holdings (NYSE:ZBH) with a Neutral rating and set a price target of $129.
May 30, 2024 | 11:18 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Goldman Sachs has initiated coverage on Zimmer Biomet Holdings with a Neutral rating and set a price target of $129.
The Neutral rating suggests that Goldman Sachs does not expect significant short-term movement in Zimmer Biomet Holdings' stock price. The price target of $129 provides a benchmark for investors.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100